Keyphrases
Parkinson's Disease
100%
Selective Antagonist
100%
Cav1.3
100%
Cav1.3 Calcium Channel
100%
Structure-activity Relationship
100%
Disubstituted
100%
Pyrimidinetrione
100%
L-type Calcium Channel
50%
Cav1.2
33%
Cav1.2 Calcium Channel
33%
Cell Death
16%
Binding Site
16%
Mitochondrial Oxidative Stress
16%
Drug Development
16%
Selective Inhibition
16%
Dopaminergic Neurons
16%
Binding Affinity
16%
Lead Optimization
16%
Potential Side Effects
16%
SAR Study
16%
Lead Diversification
16%
Cyclopentyl
16%
Channel Binding
16%
Calcium Ion Influx
16%
Medicine and Dentistry
Cav1.3
100%
Parkinson's Disease
100%
Structure-Activity Relationship
100%
Calcium Channel
100%
L-Type Calcium Channel
71%
Cav1.2
42%
Side Effect
14%
Calcium Ion
14%
Oxidative Stress
14%
Binding Affinity
14%
Dopaminergic Neuron
14%
Cell Death
14%
Binding Site
14%
Biochemistry, Genetics and Molecular Biology
Structure Activity Relation
100%
Calcium Channel
100%
Cav1.3
100%
L-Type Calcium Channel
71%
Structure Activity Relationship
42%
Cav1.2
42%
Isoform
14%
Calcium Ion
14%
Binding Site
14%
Oxidative Stress
14%
Binding Affinity
14%
Dopaminergic
14%
Cell Death
14%
Pharmacology, Toxicology and Pharmaceutical Science
Structure Activity Relationship
100%
Calcium Channel
100%
Calcium Channel L Type
100%
Parkinson's Disease
100%
Drug Development
20%
Calcium Ion
20%
Binding Site
20%
Side Effect
20%
Dopamine Receptor Stimulating Agent
20%